These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 2823620

  • 1. Detection of early pregnancy factor-like activity in women with gestational trophoblastic tumors.
    Mehta AR, Shahani SK.
    Am J Reprod Immunol Microbiol; 1987 Jul; 14(3):67-9. PubMed ID: 2823620
    [Abstract] [Full Text] [Related]

  • 2. Early pregnancy factor (EPF) as tumour marker in two patients with trophoblastic tumour.
    Bojahr B, Straube W, Römer T.
    Arch Gynecol Obstet; 1993 Jul; 252(4):215-8. PubMed ID: 8390229
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic reliability of simultaneous measurements of beta human chorionic gonadotropin and pregnancy-specific beta-1-glycoprotein in serum of patients with trophoblastic disease.
    Takayama M, Soma H, Isaka K, Okudera K, Ogawa T, Kikuchi K.
    Gynecol Obstet Invest; 1987 Jul; 23(3):151-6. PubMed ID: 3036671
    [Abstract] [Full Text] [Related]

  • 4. A study of early pregnancy factor activity in the sera of women with trophoblastic tumor.
    Fan X, Yan L, Jia S, Ma A, Qiao C.
    Am J Reprod Immunol; 1999 Mar; 41(3):204-8. PubMed ID: 10326623
    [Abstract] [Full Text] [Related]

  • 5. The beta-subunit of chorionic gonadotrophin as a tumour marker in gestational trophoblastic disease.
    Khoo SK, Daunter B.
    Aust N Z J Obstet Gynaecol; 1980 Feb; 20(1):35-42. PubMed ID: 6248013
    [Abstract] [Full Text] [Related]

  • 6. Pregnancy-specific beta-1-glycoprotein in trophoblastic disease.
    Rutanen EM, Seppälä M.
    J Clin Endocrinol Metab; 1980 Jan; 50(1):57-61. PubMed ID: 6243133
    [No Abstract] [Full Text] [Related]

  • 7. Serum placental lactogen activity in patients with molar pregnancy and trophoblastic tumors--a reliable index of malignancy.
    Goldstein DP.
    Am J Obstet Gynecol; 1971 Jun 15; 110(4):583-7. PubMed ID: 4325820
    [No Abstract] [Full Text] [Related]

  • 8. Serum interleukin-2 and soluble interleukin-2 receptor in gestational trophoblastic diseases.
    Shaarawy M, Darwish NA, Abdel-Aziz O.
    J Soc Gynecol Investig; 1996 Jun 15; 3(1):39-46. PubMed ID: 8796806
    [Abstract] [Full Text] [Related]

  • 9. Radioimmunoassay of the beta-subunit of human chorionic gonadotropin, monitor of chemotherapy in gestational trophoblastic neoplasm.
    Jones WB, Lehr M, Lewis JL.
    Surg Forum; 1973 Jun 15; 24():563-5. PubMed ID: 4377042
    [No Abstract] [Full Text] [Related]

  • 10. [Case observations on the significance of early pregnancy factor as a tumor marker].
    Bojahr B, Straube W, Reddemann H.
    Zentralbl Gynakol; 1993 Jun 15; 115(3):125-8. PubMed ID: 7682025
    [Abstract] [Full Text] [Related]

  • 11. Differential production of human chorionic gonadotropin and free subunits in gestational trophoblastic disease.
    Ozturk M, Berkowitz R, Goldstein D, Bellet D, Wands JR.
    Am J Obstet Gynecol; 1988 Jan 15; 158(1):193-8. PubMed ID: 2447774
    [Abstract] [Full Text] [Related]

  • 12. Immunohistochemistry in the diagnosis of the gestational trophoblastic disease.
    Lösch A, Kainz C.
    Acta Obstet Gynecol Scand; 1996 Sep 15; 75(8):753-6. PubMed ID: 8906012
    [Abstract] [Full Text] [Related]

  • 13. Pregnancy-specific proteins as markers for gestational trophoblastic disease.
    Horne CH, Rankin R, Bremner RD.
    Int J Gynecol Pathol; 1984 Sep 15; 3(1):27-40. PubMed ID: 6203853
    [No Abstract] [Full Text] [Related]

  • 14. Circulating concentrations of specific placental proteins (human chorionic gonadotropin, pregnancy-specific beta-1 glycoprotein, and placental protein 5) in untreated gestational trophoblastic tumors.
    Lee JN, Salem HT, Al-Ani AT, Chard T, Huang SC, Ouyang PC, Wei PY, Seppälä M.
    Am J Obstet Gynecol; 1981 Mar 15; 139(6):702-4. PubMed ID: 6971058
    [Abstract] [Full Text] [Related]

  • 15. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
    Shaarawy M, el-Shobokshy AS, el-Noury AI.
    Cytokine; 1995 Feb 15; 7(2):171-5. PubMed ID: 7540057
    [Abstract] [Full Text] [Related]

  • 16. Partial hydatidiform mole with subsequent trophoblastic tumor; a case report.
    Vejerslev LO, Larsen G, Jacobsen M.
    Eur J Obstet Gynecol Reprod Biol; 1991 Jun 05; 40(1):73-7. PubMed ID: 1649776
    [Abstract] [Full Text] [Related]

  • 17. [Hydatidiform mole, trophoblastic tumor/choriocarcinoma].
    Luschin-Ebengreuth G, Petru E, Pickel H.
    Gynakol Geburtshilfliche Rundsch; 1992 Jun 05; 32 Suppl 1():125-6. PubMed ID: 1337488
    [No Abstract] [Full Text] [Related]

  • 18. Trophoblastic disease monitoring: Evaluation of pregnancy-specific beta 1-glycoprotein.
    O'Brien TJ, Engvall E, Schlaerth JB, Morrow CP.
    Am J Obstet Gynecol; 1980 Oct 01; 138(3):313-20. PubMed ID: 6251725
    [Abstract] [Full Text] [Related]

  • 19. Persistent gestational trophoblastic tumour with partial hydatidiform mole as the antecedent pregnancy.
    Chen RJ, Huang SC, Chow SN, Hsieh CY, Hsu HC.
    Br J Obstet Gynaecol; 1994 Apr 01; 101(4):330-4. PubMed ID: 8199080
    [Abstract] [Full Text] [Related]

  • 20. Serum SP1 and hCG beta-subunit (hCG beta) levels in choriocarcinoma, invasive mole, and hydatidiform mole--clinical significance of SP1/hCG beta ratio.
    Sakuragi N.
    Gynecol Oncol; 1982 Jun 01; 13(3):393-8. PubMed ID: 6178652
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.